Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: A randomized, controlled trial

David B. Badesch, Victor F. Tapson, Michael D. McGoon, Bruce H. Brundage, Lewis J. Rubin, Fredrick M. Wigley, Stuart Rich, Robyn J. Barst, Pamela S. Barrett, Kenneth M. Kral, Maria M. Jöbsis, James E. Loyd, Srinivas Murali, Adaani Frost, Reda Girgis, Robert C. Bourge, David D. Ralph, C. Gregory Elliott, Nicholas S. Hill, David LanglebenRobert J. Schilz, Vallerie V. McLaughlin, Ivan M. Robbins, Bertron M. Groves, Shelley Shapiro, Thomas A. Medsger, Sean P. Gaine, Evelyn Horn, James C. Decker, Katharine Knobil

Research output: Contribution to journal › Article › peer-review

956 Scopus citations

Fingerprint

Dive into the research topics of 'Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: A randomized, controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences